SALT LAKE CITY—ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laboratory research and development, today announced an investment in Techcyte Inc. as part of the Orem, Utah-based company’s new $21 million funding round.
Inaugural ARUP Laboratories Symposium Offers Strategies to Help Lab Leaders Advance Their Labs’ Value in Their Healthcare Systems
SALT LAKE CITY—Northwell Health president and CEO Michael J. Dowling, MSW, will be the keynote speaker for ARUP Laboratories’ inaugural Lab Leadership Symposium, “Creating Connections: Advancing Your Lab’s Value in the Healthcare System,” which will be held Thursday, October 21, 2021, via Zoom.
SEOUL, South Korea—Deep Bio, a leading company in artificial intelligence (AI) cancer diagnostics, announced a research collaboration agreement with ARUP Laboratories, a top U.S. reference laboratory and worldwide leader in innovative laboratory research and development.
SALT LAKE CITY—GenomOncology announced today that ARUP Laboratories (ARUP) has chosen to extend its use of the GenomOncology (GO) Precision Oncology API Suite by integrating the GO Clinical Trial and Therapy Matching APIs into its current workflows to strengthen its patient care offerings.
ARUP Joins University of Utah Health, Intermountain Healthcare, and American Red Cross in Plea for Blood Donations
David Beverly of Magna, Utah, said he was staying close to home, quarantining against illness and psyching himself up for a living-donor liver transplant that would save his father’s life. Then he got the call.
ARUP’s Clinical Trials Group Lauds FDA Approval of New Precision Therapy to Treat Advanced Systemic Mastocytosis
The U.S. Food and Drug Administration (FDA) recently approved a new precision therapy developed by Blueprint Medicines for adults with advanced systemic mastocytosis, a rare and potentially fatal hematologic malignancy.
Adam Barker, PhD, has been appointed as ARUP’s chief scientific officer, a role in which he will lead the newly formed New Technologies Group.
Rapid antigen testing has been used widely during the COVID-19 pandemic to quickly determine infection status in settings such as schools or the workplace, but its role has changed as the pandemic has evolved.
SALT LAKE CITY—ARUP Laboratories, one of the nation’s largest reference laboratories, today held a ribbon cutting ceremony to officially open its new four-story, 220,000-square-foot laboratory facility in Salt Lake City. ARUP employees, executives, and board members were on hand for the celebration, along with University of Utah leaders and Utah public officials.
ARUP Announces Partnership with TellBio for Use of TellBio’s Novel Circulating Tumor Cells Technology
SALT LAKE CITY—ARUP Laboratories today announced it has signed a strategic agreement with Massachusetts-based TellBio Inc. to use the development-stage biotechnology company’s TellDx circulating tumor cells (CTCs) technology in several research applications.
University of Utah, ARUP, and Techcyte Develop NanoSpot.AI, a New Ultra-Fast Test for COVID-19 Antibodies
SALT LAKE CITY–The University of Utah (the U), ARUP Laboratories, and Techcyte Inc. announced today that they have formed a partnership to develop NanoSpot.AI, a less than five-minute, easy-to-administer SARS-CoV-2 antibody test.